At a Glance
| Alpha-GPC | Citicoline | |
|---|---|---|
| Class | Nootropic | Nootropic |
| Common Dose (oral) | 300–500 mg | 250–1000 mg |
| Total Duration | 2.2–5.3 hrs | 5.5–8.5 hrs |
| Routes | oral | oral |
| Effects | 16 documented | 15 documented |
Alpha-GPC, a Nootropic, and Citicoline, a Nootropic, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Nootropics, meaning they share a common pharmacological foundation. They share 10 documented effects in common, with 6 effects unique to Alpha-GPC and 5 unique to Citicoline. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Alpha-GPC | Citicoline | |
|---|---|---|
| Class | Nootropic | Nootropic |
| Common Dose (oral) | 300–500 mg | 250–1000 mg |
| Total Duration | 2.2–5.3 hrs | 5.5–8.5 hrs |
| Routes | oral | oral |
| Effects | 16 documented | 15 documented |
| Level | Alpha-GPC | Citicoline |
|---|---|---|
| Threshold | 50 mg | 50 mg |
| Light | 100–300 mg | 100–250 mg |
| Common | 300–500 mg | 250–1000 mg |
| Strong | 500–1000 mg | 1000–2000 mg |
| Heavy | 1000 mg | 2000 mg |
Alpha-GPC
Citicoline
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.
No dangerous interactions recorded.